Skip to main content

Table 4 Multivariate regression analysis for predicting factors of pCR rate

From: Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

Variables   Adjusted OR (95% CI) P
MEG3 rs10132552 CC + TC vs. TT 2.79(1.096–7.103) 0.031*
Tumor size Continuous Variable 1.002(0.96–1.045) 0.943
Age Continuous Variable 0.951(0.907–0.996) 0.035*
Ki67 Continuous Variable 1.059(1.033–1.086) < 0.001*
Her2 expression Positive vs. negative 11.718(3.974–34.554) < 0.001*
Hormone receptor Positive vs. negative 0.241(0.071–0.811) 0.022*
  1. Abbreviations: OR odds ratio, HER2 human epidermal growth factor receptor −2
  2. *P < 0.05